Pranlukast, a Leukotriene Receptor Antagonist, Inhibits Interleukin-5 Production via a Mechanism Distinct from Leukotriene Receptor Antagonism

Publisher： Karger

E-ISSN： 1423-0097|136|2|165-172

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.136, Iss.2, 2005-02, pp. : 165-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Position of Pranlukast, a Cysteinyl Leukotriene Receptor Antagonist, in the Long-Term Treatment of Asthma

By  

Respiration, Vol. 71, Iss. 3, 2004-05 ,pp. : 225-232

Karger

Access to resources Recommend Favorite

Pranlukast, a Cysteinyl Leukotriene Type 1 Receptor Antagonist, Attenuates the Progression but Not the Onset of Silica-Induced Pulmonary Fibrosis in Mice

By  

International Archives of Allergy and Immunology, Vol. 158, Iss. 3, 2012-02 ,pp. : 241-251

Karger

Access to resources Recommend Favorite

Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 159-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of the Cysteinyl Leukotriene Antagonist Pranlukast on Transendothelial Migration of Eosinophils

By  

International Archives of Allergy and Immunology, Vol. 137, Iss. 1, 2005-06 ,pp. : 2-6

Karger

Access to resources Recommend Favorite

Inhibitory Effect of the Leukotriene B4 Receptor Antagonist against Hypomagnesic Diet‐induced Dermatitis in Hairless Rats

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 8, 1992-08 ,pp. : 456-460

John Wiley & Sons Inc

Access to resources Recommend Favorite